R&D JP Morgan 2023 – Alexandre LeVert Editor-in-chief Jonah Comstock caught up with Alexandre LeVert, chairman, CEO, and co-founder of Osivax, on the sidelines of JP Morgan in San Francisco at the beginning of January of this year.&nbs
Events Partner Content 4th Annual Cell Engager Summit | May 24-26 | Boston, MA Learn from the pioneers of immunotherapy
Events Partner Content Cell-Mediated Therapies for Infectious Disease Summit Cell-Mediated Therapies for Infectious Disease Summit
Views & Analysis How T-cell therapy saved my life Judy Perkins’ stage 4 cancer was eradicated after she joined a clinical trial for T-cell therapy.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends